ZIMMER BIOMET HOLDINGS

(ZBH)
  Report
Delayed Nyse  -  05/27 04:04:53 pm EDT
119.83 USD   -0.68%
05/27Needham Downgrades Zimmer Biomet Holdings to Hold From Buy, Removes $143 Price Target, Citing Market Share Loss, Inflationary Pressure, Normalizing Sector Growth
MT
05/26Zimmer Biomet Adds Chief Communications, Administration Officer
MT
05/26Zimmer Biomet Holdings, Inc. Appoints Keri P. Mattox as Chief Communications and Administration Officer
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Retreat This Afternoon

01/21/2022 | 04:05pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
APPLIED DNA SCIENCES, INC. 4.24% 1.23 Delayed Quote.-69.40%
CUREVAC N.V. 2.65% 19.35 Delayed Quote.-43.60%
MEDTRONIC PLC -0.36% 99.08 Delayed Quote.-4.22%
NASDAQ COMP. 3.33% 12131.13 Real-time Quote.-22.46%
ZIMMER BIOMET HOLDINGS -0.68% 119.83 Delayed Quote.-3.74%
All news about ZIMMER BIOMET HOLDINGS
05/27Needham Downgrades Zimmer Biomet Holdings to Hold From Buy, Removes $143 Price Target, ..
MT
05/26Zimmer Biomet Adds Chief Communications, Administration Officer
MT
05/26Zimmer Biomet Holdings, Inc. Appoints Keri P. Mattox as Chief Communications and Admini..
CI
05/19ZIMMER BIOMET HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders (form 8..
AQ
05/17Citigroup Adjusts Price Target on Zimmer Biomet Holdings to $125 From $135, Maintains N..
MT
05/17Zimmer Biomet Holdings Maintains Dividend at $0.24/Share; Payable on July 29 to Shareho..
MT
05/17Zimmer Biomet Holdings, Inc. Approves Quarterly Dividend for Second Quarter of 2022, Pa..
CI
05/16ZIMMER BIOMET HOLDINGS, INC. : Change in Directors or Principal Officers, Regulation FD Di..
AQ
05/16Zimmer Biomet Holdings, Inc. Appoints Paul Stellato as Controller and Chief Accounting ..
CI
05/11Zimmer Biomet Debuts First-of-its-Kind Artificial Intelligence Capabilities for Omni Su..
AQ
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS
More recommendations
Financials (USD)
Sales 2022 6 836 M - -
Net income 2022 735 M - -
Net Debt 2022 5 053 M - -
P/E ratio 2022 37,3x
Yield 2022 0,82%
Capitalization 25 114 M 25 114 M -
EV / Sales 2022 4,41x
EV / Sales 2023 4,09x
Nbr of Employees 19 500
Free-Float 63,2%
Chart ZIMMER BIOMET HOLDINGS
Duration : Period :
Zimmer Biomet Holdings Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZIMMER BIOMET HOLDINGS
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 119,83 $
Average target price 131,76 $
Spread / Average Target 9,96%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Ivan Tornos Chief Operating Officer
Angela Main Chief Compliance Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS-3.74%25 114
ABBOTT LABORATORIES-17.09%204 317
MEDTRONIC PLC-4.22%131 850
BECTON, DICKINSON AND COMPANY2.74%73 108
HOYA CORPORATION-19.93%39 352
BAXTER INTERNATIONAL INC.-11.28%38 349